Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010
Net revenues:
Product revenue	$ 6,278,893	$ 6,562,322	$ 12,299,955	$ 12,676,377
Other revenue	0	0	0	6,933
Revenues, net	6,278,893	6,562,322	12,299,955	12,683,310
Costs and expenses:
Cost of goods sold	4,284,316	4,178,261	7,852,825	8,266,985
Marketing, general and administrative	2,571,351	2,777,128	5,047,749	5,441,387
Research and development	320,597	406,389	702,540	802,617
Total costs and expenses	7,176,264	7,361,778	13,603,114	14,510,989
Loss from operations	(897,371)	(799,456)	(1,303,159)	(1,827,679)
Other (expense) and income:
Equity in Ocular Telehealth Management, LLC	446	(11,507)	1,144	(34,145)
Loss on disposal of assets	(86,885)	0	(86,885)	0
Interest income	58	45	100	111
Interest expense	(88,059)	(78,231)	(170,551)	(159,878)
Total other (expense) income	(174,440)	(89,693)	(256,192)	(193,912)
Net loss from continuing operations before taxes	(1,071,811)	(889,149)	(1,559,349)	(2,021,591)
Provision for income taxes	0	0	0	0
Net loss from continuing operations	(1,071,811)	(889,149)	(1,559,349)	(2,021,591)
Net income (loss) from discontinued operations including loss of $2,216,046 on liquidation of BHH net assets during 2011	(2,463,189)	(159,450)	(2,765,300)	323,828
Net loss	$ (3,535,000)	$ (1,048,599)	$ (4,324,649)	$ (1,697,763)
Net income (loss) per share, Basic:
Continuing operations	$ (0.14)	$ (0.12)	$ (0.21)	$ (0.27)
Discontinued operations	$ (0.33)	$ (0.02)	$ (0.37)	$ 0.04
Net income (loss)	$ (0.47)	$ (0.14)	$ (0.58)	$ (0.23)
Net income (loss) per share, Diluted:
Continuing operations	$ (0.14)	$ (0.12)	$ (0.21)	$ (0.27)
Discontinued operations	$ (0.33)	$ (0.02)	$ (0.37)	$ 0.04
Net income (loss)	$ (0.47)	$ (0.14)	$ (0.58)	$ (0.23)
Weighted average shares - basic	7,526,430	7,526,430	7,526,430	7,526,430
Weighted average shares - diluted	7,526,430	7,526,430	7,526,430	7,526,430